Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment
- PMID: 18986330
- DOI: 10.1111/j.1440-1681.2008.05061.x
Quercetin activates human Kv1.5 channels by a residue I502 in the S6 segment
Abstract
1. The aims of the present study were to investigate the pharmacological effects of quercetin on wild-type (WT) and mutant (I502A) human (h) Kv1.5 channel currents (I(kur)) and to identify whether mutation in the S6 segment is critical to activation of I(kur) by quercetin. 2. Experiments were performed on WT and site-directed mutant hKv1.5 channels, which were stably expressed in Xenopus oocytes using the two-microelectrode voltage-clamp technique. 3. Quercetin increased WT hKv1.5 channel current in a concentration-, voltage- and time-dependent manner, with an EC(50) of 37.8 micromol/L and a negative shift in the steady state activation and inactivation curves. Quercetin accelerated channel activation and inactivation, significantly decreasing activation and inactivation time constants. However, mutating the I502 residue to Ala abolished the activating effect of quercetin. Quercetin did not modify the activation and inactivation kinetics of I502A channels. As an anti-oxidant, tanshinone IIA (4 micromol/L) inhibited the H(2)O(2)-induced activation of WT hKv1.5 channels. In contrast, quercetin had no significant effect. 4. We conclude that: (i) quercetin preferentially binds to and increases the current amplitude of WT hKv1.5 channels; (ii) Ile502, an aliphatic and neutral amino acid residue residing in the S6 segment, is important in quercetin binding; and (iii) quercetin-induced changes in the properties of WT hKv1.5 channels may be foreign to its own anti-oxidant action.
Similar articles
-
Verapamil blocks HERG channel by the helix residue Y652 and F656 in the S6 transmembrane domain.Acta Pharmacol Sin. 2007 Jul;28(7):959-67. doi: 10.1111/j.1745-7254.2007.00562.x. Acta Pharmacol Sin. 2007. PMID: 17588331
-
Interaction of propofol with voltage-gated human Kv1.5 channel through specific amino acids within the pore region.Eur J Pharmacol. 2015 Oct 5;764:622-632. doi: 10.1016/j.ejphar.2015.08.007. Epub 2015 Aug 6. Eur J Pharmacol. 2015. PMID: 26256861
-
Cinnamyl-3,4-dihydroxy-alpha-cyanocinnamate and nordihydroguaiaretic acid inhibit human Kv1.5 currents independently of lipoxygenase.Eur J Pharmacol. 2008 Dec 14;600(1-3):18-25. doi: 10.1016/j.ejphar.2008.10.010. Epub 2008 Oct 10. Eur J Pharmacol. 2008. PMID: 18930721
-
Kvbeta1.3 reduces the degree of stereoselective bupivacaine block of Kv1.5 channels.Anesthesiology. 2007 Oct;107(4):641-51. doi: 10.1097/01.anes.0000282100.32923.5c. Anesthesiology. 2007. PMID: 17893461
-
Human glycine alpha1 receptor inhibition by quercetin is abolished or inversed by alpha267 mutations in transmembrane domain 2.Brain Res. 2007 Aug 3;1161:1-10. doi: 10.1016/j.brainres.2007.05.057. Epub 2007 Jun 13. Brain Res. 2007. PMID: 17603028
Cited by
-
Research Progress on Natural Products' Therapeutic Effects on Atrial Fibrillation by Regulating Ion Channels.Cardiovasc Ther. 2022 Mar 22;2022:4559809. doi: 10.1155/2022/4559809. eCollection 2022. Cardiovasc Ther. 2022. PMID: 35387267 Free PMC article. Review.
-
Quercetin-induced Growth Inhibition in Human Bladder Cancer Cells Is Associated with an Increase in Ca-activated K Channels.Korean J Physiol Pharmacol. 2011 Oct;15(5):279-83. doi: 10.4196/kjpp.2011.15.5.279. Epub 2011 Oct 31. Korean J Physiol Pharmacol. 2011. PMID: 22128260 Free PMC article.
-
Flavonoids as Modulators of Potassium Channels.Int J Mol Sci. 2023 Jan 9;24(2):1311. doi: 10.3390/ijms24021311. Int J Mol Sci. 2023. PMID: 36674825 Free PMC article. Review.
-
Challenges Faced with Small Molecular Modulators of Potassium Current Channel Isoform Kv1.5.Biomolecules. 2019 Dec 19;10(1):10. doi: 10.3390/biom10010010. Biomolecules. 2019. PMID: 31861703 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials